Categorynews

Industry Veteran Tom Schwenger to Join Veeva as President and COO

April 1, 2019 Off By BusinessWire

25-year life sciences industry veteran to join September 2019

PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/LifeSciences?src=hash" target="_blank"gt;#LifeScienceslt;/agt;–Veeva
Systems (NYSE:VEEV) today announced that Tom Schwenger will join the
company as president and COO in September 2019 to lead strategy, sales,
and services. Schwenger brings more than 25 years of life sciences
industry expertise, having built high performing teams leading strategy
and technology transformations for many of the world’s top
pharmaceutical, biotech, and medical device companies.

Schwenger has dedicated the majority of his career to helping companies
advance how medical treatments are discovered, developed, and delivered
to patients around the world. He currently has regional responsibility
for Accenture’s Northeast Products Industries Practice which includes
life sciences and related industries. Previously, he led the growth of
its North American Life Sciences Practice.

“I look forward to joining the exceptional Veeva team,” said Schwenger.
“Veeva is uniquely positioned to help the industry bring products to
market more efficiently and effectively, which is now more important
than ever.”

“We are excited to welcome Tom to the Veeva leadership team. He is
widely respected for all he’s done to advance life sciences throughout
his career and brings an outstanding track record operating high
performing organizations,” said Peter Gassner, founder and CEO of Veeva
Systems. “As we look ahead to our next phase of growth, Tom’s depth of
knowledge and experience will contribute to the continued success of our
customers.”

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.

Additional Information

Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems

Follow @veevasystems on Twitter: twitter.com/veevasystems

Like Veeva on Facebook: facebook.com/veevasystems

Forward-looking Statements

This release contains forward-looking statements, including the
quotations from management and Mr. Schwenger and other statements
regarding Mr. Schwenger’s appointment to president and COO. Any
forward-looking statements contained in this press release are based
upon Veeva’s current plans, estimates, and expectations and are not a
representation that such plans, estimates, or expectations will be
achieved. These forward-looking statements represent Veeva’s
expectations as of the date of this press announcement. Subsequent
events may cause these expectations to change, and Veeva disclaims any
obligation to update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks and
uncertainties that may cause actual results to differ materially,
including unexpected events related to Mr. Schwenger’s appointment to
President and COO, including the timing of such appointment.

Additional risks and uncertainties that could affect Veeva’s financial
results are included under the captions, “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results
of Operations,” in the company’s filing on Form 10-K for the period
ended January 31, 2019. This is available on the company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.